Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

A legfontosabb adatok

Ki végzi
Dartmouth-Hitchcock Medical Center
Hol
Lebanon (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
125 fő, tervezett
Kezdés
2025. nov. 3.
Várható befejezés
2028. dec.
A vizsgálat típusa
Beavatkozással járó, 4 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • HOBSCOTCH-CA
A regiszteradat frissítve
2025. november 21.

Ki vehet részt

The trial is looking for adults who have survived a primary brain tumor (not glioblastoma) and have memory or thinking problems. A caregiver can also join, but this is optional.

Életkor
18 years and older.
Nem
All sexes.
A betegség stádiuma
A primary brain tumor with expected survival of 2 years or more, such as low-grade glioma, oligodendroglioma, IDH mutant astrocytoma or meningioma. It must be seen on CT or MRI and confirmed by a tissue test. Some people treated for meningioma with radiotherapy may not need the tissue test.
Korábbi kezelés
Surgery and/or radiation must have ended at least 3 months before joining. People on chemotherapy or other systemic therapy can join. Doses of all medicines acting on the brain and nerves must be stable for one month before joining.
A részvétel fő kizáró okai
  • Glioblastoma (GBM).
  • A disease where brain cells slowly break down, such as Alzheimer's disease or Parkinson's disease.
  • A current serious mental health problem or substance abuse.
  • Not able to read and speak English well.
  • No internet or telephone access for the sessions.
A regiszter összes feltétele (20)A regiszter feltételeinek elrejtése

Ki vehet részt

  • 18 + years
  • Service members, Veterans and civilians with a diagnosis of brain cancer (excluding glioblastoma)
  • Diagnosis of primary brain tumor with expected survival of 2 years or greater (e.g., low-grade glioma, oligodendroglioma, IDH mutant astrocytoma, meningioma) defined as the presence of a primary lesion on neuroimaging (CT or MRI), confirmed by histopathological examination (Note: some patients being treated for meningioma may be treated with radiotherapy without need for initial histopathologic confirmation)
  • Patients undergoing surgical and/or radiation therapy will have completed their treatment at least 3 months prior to being enrolled in trial (Note: patients receiving chemotherapy or other systemic therapy will be included)
  • Stable on all CNS acting medications for one month prior to enrollment
  • Subjective cognitive complaints
  • Literate and proficient in English
  • Internet access for the pre-session and Session 1 of the HOBSCOTCH-CA program; telephone access for sessions 2-8
  • Age 18 +
  • Caregiver to a patient with a confirmed diagnosis of brain cancer/tumor survivor
  • CA Subject has given permission for their caregiver to participate
  • Literate and proficient in English
  • Internet access (for Pre-HOBSCOTCH and Session 1)
  • Telephone access (for Session 8)

Ki nem vehet részt

  • Presence of a neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease)
  • Acute psychiatric disorder or substance abuse
  • Significant visual impairment precluding reading or writing
  • Patients with glioblastoma (GBM)
  • No reliable telephone or internet access

Egyéb feltételek

  • CA Participants will be referred to the study by their providers (Oncologist) who will be made aware of the study and inclusion/exclusion criteria. Inclusion Criteria 2. - 5. and Exclusion Criteria 1. - 3. will be confirmed by referring providers. Participants who learn about the study here and elsewhere will be instructed on how to confirm their eligibility with their provider

Alkalmassági kérdőív

Ez nem döntés: hogy ki vehet részt, azt csak a vizsgálat csapata mondhatja meg.

  • Életkor

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • Dartmouth-Health LebanonLebanon, Egyesült ÁllamokContact: Kathryn GiordanoRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the ability of the HOBSCOTCH-CA program to improve quality of life in caregivers of patients with brain cancer/tumor and to reduce caregiver burden. Enrolling with a Caregiver is optional for CA participants.

A teljes eredeti leírásKevesebb

Investigators will compare two groups of CA participants and their Caregiver (enrolling with a Caregiver is optional): one who receives HOBSCOCTCH-CA immediately (Group 1) and another group that will receive HOBSCOTCH-CA (Group 2) after a 3-month waiting period. Participants will be in the study for about 6 months total.

HOBSCOTCH-CA involves 45 to 60 minute one on one virtual sessions with a certified Cognitive Coach including a "pre" program session and 8 weekly sessions thereafter. Participants will learn about problem solving therapy and mindfulness or relaxation training. CA participants are asked to do short homework assignments and keep a brief daily diary on a smart phone app. All participants complete study questionnaires or surveys at enrollment, 3 months later and at 6 months (at the end of the study).

A vizsgálat 4 csoportja

  • CA Participant-Group 1A vizsgált kezelés

    After enrollment and completion of baseline assessments, CA Participant Group 1 will receive the HOBSCOTCH-PTE intervention consisting of 1:1 sessions delivered once per week including: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 6 telephone sessions (option to do on webcam) * 1 wrap-up session (webcam or telephone)

    Kezelés: HOBSCOTCH-CA

  • CA Participant-Group 2Már használt kezelés, összehasonlításként

    After a 3-month waiting period and having completed baseline and 3-month study assessments, CA Participant Group 2 will receive the HOBSCOTCH-CA intervention consisting of 1:1 sessions delivered once per week including: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 6 telephone sessions (option to do on webcam) * 1 wrap-up session (webcam or telephone)

    Kezelés: HOBSCOTCH-CA

  • CA Participant Caregiver-Group 1A vizsgált kezelés

    After enrollment and completion of baseline assessments, CA Participant Caregiver Group 1 will receive an adapted version of HOBSCOTCH-CA alongside the CA participant by attending: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 1 wrap-up session (webcam or telephone)

    Kezelés: HOBSCOTCH-CA

  • CA Participant Caregiver-Group 2Már használt kezelés, összehasonlításként

    After a 3-month waiting period and having completed baseline and 3-month study assessments, CA Participant Caregiver Group 2 will receive an adapted version of HOBSCOTCH-CA alongside the CA participant by attending: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 1 wrap-up session (webcam or telephone)

    Kezelés: HOBSCOTCH-CA

Következő lépések

Az orvosodnak

Kérdőlap az orvosnak

PDF az orvosodnak: mit vizsgál a vizsgálat, ki vehet részt, és 1 kérdés a részvételi feltételekről, hellyel a válaszoknak és a jegyzeteknek.

A PDF letöltése

PDF, US Letter, 1–2 oldal. A4 méretben

A vizsgálati csapatnak

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT06930846: ki vehet részt
A regiszteradat frissítve
2025. november 21.